Healthcare

December 22, 2014

1

Health cooperation Cuban medics eye Algerian market

Minister of Health, Population and Hospital Reform Abdelmalek Boudiaf, met Friday in Havana, on the sidelines of the 19th Algerian-Cuban Joint Commission with Cuban officials from several sectors.

He held talks with First Deputy Minister of Foreign Affairs Marcelino Medina Gonzalez, who praised the level of the political relations between Algeria and Cuba and their extension to the economic and health fields.

He also met with his Cuban counterpart Roberto Morales Ojeda, who highlighted the development of bilateral relations in the health sector.Boudiaf also discussed with Vice President...

Continue Reading >

December 21, 2014

2

Health minister meets in Havana with several Cuban officials

Minister of Health, Population and Hospital Reform Abdelmalek Boudiaf, met Friday in Havana, on the sidelines of the 19th Algerian-Cuban Joint Commission with Cuban officials from several sectors.


He held talks with First Deputy Minister of Foreign Affairs Marcelino Medina Gonzalez, who praised the level of the political relations between Algeria and Cuba and their extension to the economic and health fields.


"......

Continue Reading >

December 20, 2014

3

Algerian-Cuban relations raised to real partnership, says Boudiaf

Minister of Health, Population and Hospital Reform Abdelmalek Boudiaf said, Thursday in Havana (Cuba), that the Algerian-Cuban cooperation relations are nowraised to a real partnership.


In an address at the end of the 19th session of the Algerian-Cuban Joint Committee, held from 14 to 19 December 2014, Boudiaf highlighted the strengthening of bilateral cooperation relations"...

Continue Reading >

December 19, 2014

4

Celgene Receives Positive CHMP Opinion to Extend REVLIMID® (Lenalidomide) for Continuous Use in Patients with Newly Diagnosed Multiple Myeloma and Ineligible for Transplant

Celgene International Sàrl, a wholly owned subsidiary of Celgene Corporation (NASDAQ: CELG), today announced that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion for continuous oral treatment with REVLIMID® in adult patients with previously untreated multiple myeloma who are not eligible for stem cell transplantation.


The"...

Continue Reading >

December 18, 2014

5

Increase in Algeria’s medicine imports in first 10 months of 2014

Algeria’s imports of pharmaceutical products reached $2.07 billion in the first 10 months of 2014 against $1.65 billion during the same period of 2013, rise of more than 25%, said Wednesday the Algerian Customs.


The overall quantities of imported pharmaceutical products totalled 25,386 tonnes against 26,471 tonnes during the same period in 2013, a drop by nearly"...

Continue Reading >

December 17, 2014

6

Cocoona Utilizes Breakthrough Form of Breast Augmentation 1 in 10 Ladies Have Had or Seriously Thought about Having Breast Enhancement

The Cocoona Centre for Aesthetic Transformation, is now utilizing a breakthrough concept of cosmetic and reconstructive breast augmentation.


Composite Breast Augmentation, a new procedure introduced in 2013 and published in a peer-reviewed plastic surgery journal, combines the use of fat grafting to an implanted breast and increases the"...

Continue Reading >

December 16, 2014

7

48 permits to exploit thermal spas issued so far

Minister of Tourism and Craft Industry Nouria Yamina Zerhouni said Monday, in Algiers, that so far 48 permits have been issued to exploit thermal spas.


Zerhouni, who was the guest of Forum of the Daily “El Moudhahid,” underlined that 18 thermal spas are under construction and 14 others are stalled for various reasons concerning the investors themselves.

...

Continue Reading >

December 15, 2014

8

First trial of a novel oral anticoagulant starts in prevention of recurrent stroke due to a blood clot of undetermined source

  • First patient enrolled in RE-SPECT ESUSTM, which evaluates dabigatran in prevention of recurrent Embolic Stroke of Undetermined Source (ESUS)
  • Patients who suffer an ESUS are at high risk of another fatal or disabling stroke due to lack of effective treatment options1–4
  • RE-SPECT ESUSTM aims to close gaps in clinical data and knowledge on prevention of recurrent ESUS
  • RE-VOLUTIONTM clinical study programme for dabigatran encompasses 60,000 patients5

For Non-US/Non-UK/Non-Canadian"...

Continue Reading >

December 13, 2014

9

Algerian-British Forum on Investment in Algeria: Inking of two agreements in health field

Two agreements in the field of health were signed Wednesday in London at the end of the Algerian-British Forum on Trade and Investment.


The first agreement signed by the public pharmaceutical group SAIDAL and the international group CLINICA, specialized in clinical research and present in Algeria since 2007.


"...

Continue Reading >

December 11, 2014

10

The 2nd Annual Gulf Obesity Surgery Society (GOSS) Meeting addresses the world’s biggest public health problem today in Dubai

The 2nd Annual Gulf Obesity Surgery Society (GOSS) Meeting, one of the biggest obesity events in the Middle East commenced today at the Raffles Hotel Dubai under the patronage of Dubai Health Authority (DHA).


Hosted by the Emirates Obesity and Metabolic Surgery Interest Group (EOMSIG), the conference is the only dedicated platform in the Middle East to address obesity which"...

Continue Reading >